Neumomir

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNeumomir
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTelomerase reverse transcriptase activators
TargetsTelomerase reverse transcriptase
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversidad Autónoma De Madrid
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdvanced Medical ProjectsUniversidad Autónoma De Madrid
Active IndicationsN/A
Inactive IndicationsIdiopathic Pulmonary Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A